These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 13383472

  • 21. [Influence of subcutaneously and intramuscularly administered zymosan on the properdin titer of serum and on leukocyte count in animal experiments].
    ZSEBOK Z, WACHTL I, SZY S, SELLEI G.
    Orv Hetil; 1960 Feb 14; 101():226-9. PubMed ID: 13847797
    [No Abstract] [Full Text] [Related]

  • 22. [Validity and limitations in the determination of serum properdin by means of zymosan].
    ZANUSSI C, TASCHINI P, SELVA G, ORTOLANI C.
    Boll Ist Sieroter Milan; 1958 Feb 14; 37(5-6):237-45. PubMed ID: 13560652
    [No Abstract] [Full Text] [Related]

  • 23. EVIDENCE FOR IMMUNOLOGICAL SPECIFICITY OF THE PROPERDIN SYSTEM; DEMONSTRATION, ISOLATION AND PROPERTIES OF A SERUM FACTOR WHICH INTERACTS WITH ZYMOSAN AND OTHER POLYSACCHARIDES AT 0 DEGREES CENTIGRADE.
    BLUM L.
    J Immunol; 1964 Jan 14; 92():61-72. PubMed ID: 14139548
    [No Abstract] [Full Text] [Related]

  • 24. Alterations in serum properdin levels following injection of Zymosan.
    PILLEMER L, ROSS OA.
    Science; 1955 May 20; 121(3151):732-3. PubMed ID: 14372981
    [No Abstract] [Full Text] [Related]

  • 25. [OBSERVATION ON TUMORAL IMMUNITY IN CONNECTION WITH THE PROPERDIN SYSTEM].
    NAGY IS, ATS M, KOSZORU M, LUST I.
    Sangre (Barc); 1964 May 20; 17():272-4. PubMed ID: 14218362
    [No Abstract] [Full Text] [Related]

  • 26. [The properdin system].
    WENSINCK F.
    Pharm Weekbl; 1956 Oct 06; 91(20):737-44. PubMed ID: 13378963
    [No Abstract] [Full Text] [Related]

  • 27. [Preparation of a bacteriocidic serum protein (properdin)].
    ISLIKER H, LINDER E.
    Helv Physiol Pharmacol Acta; 1956 Oct 06; 14(2):C34-C35. PubMed ID: 13345236
    [No Abstract] [Full Text] [Related]

  • 28. Replacement of magnesium by cobalt and manganese in the interactions of the properdin system with bacteria and with zymosan.
    WARDLAW AC, BLUM L, PILLEMER L.
    J Immunol; 1958 Jul 06; 81(1):43-7. PubMed ID: 13563878
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of Zymosan on the properdin level of tumor patients].
    NAGY S, HARTAI F.
    Acta Biol Med Ger; 1961 Jul 06; 6():99-102. PubMed ID: 13727492
    [No Abstract] [Full Text] [Related]

  • 30. Alterations in serum lysozyme and properdin titers of mice following x-irradiation or treatment with zymosan or endotoxin.
    HOOK WA, CAREY WF, MUSCHEL LH.
    J Immunol; 1960 Jun 06; 84():569-75. PubMed ID: 14402997
    [No Abstract] [Full Text] [Related]

  • 31. [Effect of non-specific stimulation with zymosan on serum properdin level in patients with neoplasms].
    Dobrek Z, Majewski S, Maciejewski B.
    Pol Tyg Lek; 1972 Jul 12; 27(24):905-8. PubMed ID: 5040537
    [No Abstract] [Full Text] [Related]

  • 32. [Properdin, a serum factor of importance for natural resistance].
    BRO-RASMUSSEN F, KILLMANN SA.
    Nord Med; 1956 Oct 11; 56(41):1479-82. PubMed ID: 13388106
    [No Abstract] [Full Text] [Related]

  • 33. [Properdin and natural immunity].
    DE LA GARZA BRITO A.
    Rev Sanid Milit; 1955 Oct 11; 8(7-9):200-1. PubMed ID: 13298269
    [No Abstract] [Full Text] [Related]

  • 34. [Properdin, serological factor of natural immunity].
    FAYE CM.
    Gaz Med Fr; 1956 Apr 25; 63(8):771-2. PubMed ID: 13318329
    [No Abstract] [Full Text] [Related]

  • 35. [Properdin].
    FERRARI F.
    Boll Chim Farm; 1956 Jun 25; 95(6):258-66. PubMed ID: 13342173
    [No Abstract] [Full Text] [Related]

  • 36. [Relation between zymosan, properdin & tumors. 2. Behavior of properdin level in rats with benzpyrene-induced sarcomas].
    MODICA F, FUMAROLA D.
    Tumori; 1958 Jun 25; 44(6):549-54. PubMed ID: 13635873
    [No Abstract] [Full Text] [Related]

  • 37. Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides.
    LANDY M, PILLEMER L.
    J Exp Med; 1956 Sep 01; 104(3):383-409. PubMed ID: 13357692
    [Abstract] [Full Text] [Related]

  • 38. [The usefulness of various zymosan preparations in determination of properdin].
    von GRAEVENITZ, HUSMANN KH, HOEBBEL K.
    Med Exp Int J Exp Med; 1960 Sep 01; 3():230-6. PubMed ID: 13707673
    [No Abstract] [Full Text] [Related]

  • 39. [Properdin and its immunological importance; present status of the question].
    DELAUNAY A, HENON M, BAZIN S, PELLETIER M.
    Presse Med (1893); 1956 Jan 14; 64(4):65-7. PubMed ID: 13289716
    [No Abstract] [Full Text] [Related]

  • 40. [Effects of zymosan on tumor growth in experimental animals].
    LUHRS W, HEISE E, BERNDT H.
    Z Krebsforsch; 1958 Jan 14; 62(5):516-8. PubMed ID: 13625832
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.